AldostefanoPorcari Profile
AldostefanoPorcari

@aldoporcari

Followers
22
Following
12
Media
3
Statuses
9

Joined January 2023
Don't wanna be here? Send us removal request.
@aldoporcari
AldostefanoPorcari
2 years
Thrilled and incredibly honored to be awarded the #AHA23 Melvin Judkins Early Career Award 🎓. Hugely grateful to have some of the best mentors throughout this journey 💫. Special thanks to @MariannaFonta11 you are a force of nature🌪️🚀I’m honored to have you as my mentor @ucl
Tweet media one
1
0
5
@aldoporcari
AldostefanoPorcari
7 months
🌟 Deeply honored to receive the Claudio Rapezzi Memorial Award 🌟 . I extend my deepest gratitude to all the mentors who have guided me throughout my journey🇮🇹🇬🇧🌏 . This award is a tribute to Prof Rapezzi' legacy and receiving it from Marinella made it a truly special moment💫
Tweet media one
0
1
5
@aldoporcari
AldostefanoPorcari
1 year
📢 Diffuse RV uptake at SPECT/CT imaging is associated with worse outcomes in ATTR-CM🫀@CircAHA. 💫 Special thanks to all the 🇮🇹 and 🇬🇧 colleagues who have made this study possible and to Prof. Claudio Rapezzi for his invaluable support @ucl @UniTrieste .
0
1
1
@aldoporcari
AldostefanoPorcari
2 years
RT @Cardioinfo_it: Nel corso di una sessione dedicata di #SIC84 Aldostefano Porcari ha presentato i risultati di una survey relativa a 35 c….
0
3
0
@aldoporcari
AldostefanoPorcari
2 years
Incredibly honoured to present the research on SGLT2 inhibitors in ATTR-CM conducted at 14 international centres for #amyloidosis in the #LBCT session at #AHA23 Philadelphia Convention Centre. Hugely grateful to my mentor @MariannaFonta11 and the team at the NAC in London🇬🇧
Tweet media one
4
2
13
@aldoporcari
AldostefanoPorcari
2 years
RT @CVR_TomaszGuzik: EDITOR'S CHOICE: State-of-the-art Spotlight review on transthyretin cardiac amyloidosis . Exploring pathogenesis, epid….
0
19
0
@aldoporcari
AldostefanoPorcari
2 years
RT @CVR_TomaszGuzik: Our latest #CardiovascularResearch SPOTLIGHT Issue on #HeartFailure is AVAILABLE NOW. Curated by Guest Editors Carolyn….
0
12
0